Pathstone Family Office’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$365K Buy
4,284
+1,495
+54% +$142K ﹤0.01% 1202
2023
Q2
$365K Buy
2,789
+4
+0.1% +$379 0.01% 893
2023
Q1
$231K Sell
2,785
-6,569
-70% -$618K ﹤0.01% 1028
2022
Q4
$962K Buy
9,354
+4,520
+94% +$521K 0.01% 808
2022
Q3
$512K Buy
+4,834
New +$530K ﹤0.01% 1069
2021
Q1
Sell
-5
Closed 689
2020
Q4
$0 Hold
5
﹤0.01% 1150
2020
Q3
$0 Sell
5
-5
-50% -$263 ﹤0.01% 793
2020
Q2
$0 Buy
+10
New +$478 ﹤0.01% 712
2019
Q2
Sell
-31
Closed -$1K 638
2019
Q1
$1K Buy
+31
New +$1.72K ﹤0.01% 833

Other funds holding AMN

Pathstone Family Office's AMN Position: Q3 2023 in Review

Pathstone Family Office increased its AMN Healthcare (AMN) stake by 54% in Q3 2023, buying an estimated $142K and bringing the position to 4,284 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #1202.

Pathstone Family Office first reported a position in AMN in Q1 2019 and has held it in 9 quarters since. The position peaked at $962K in Q4 2022. 389 funds tracked by Wall St. Rank hold AMN as of Q3 2023.

  • Pathstone Family Office held 4,284 shares of AMN Healthcare worth $365K as of Q3 2023.
  • Pathstone Family Office bought 1,495 AMN Healthcare shares in Q3 2023, an estimated $142K.
  • AMN Healthcare made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1202 holding.
  • Pathstone Family Office first reported a position in AMN Healthcare in Q1 2019 and has held it in 9 quarters since.
  • Pathstone Family Office's AMN Healthcare position peaked at $962K in Q4 2022.
  • 389 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.